Position in ACB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$85,627
+$44,682 QoQ
Shares Held
30,691
+145.1% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Derivatives in ACB
reported options exposure · as of Dec 31, 2020CallValue
$877,536
CallShares
10,560
PutValue
$2,685,792
PutShares
32,320
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. ACB ranks #32 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
9,213,269 | $133,500,266 | |
| 2 | ZTS |
Zoetis Inc.
|
1,828,326 | $131,383,499 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
583,476 | $98,339,041 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
10,832,582 | $53,404,627 | |
| 5 | VTRS |
Viatris Inc
|
3,135,460 | $49,791,098 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
62,600 | $33,918,552 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
953,413 | $32,301,629 | |
| 8 | HLN |
Haleon plc
|
3,385,489 | $31,586,609 |
All Filings in ACB
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,627 | 30,691 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $40,945 | 12,522 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $46,456 | 11,009 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $956,466 | 160,481 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,068,914 | 252,103 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $66,849 | 15,228 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $51,440 | 12,104 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,525 | 3,831 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,369 | 4,193 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $73,490 | 16,741 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $41,599 | 87,400 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $88,054 | 150,527 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $62,327 | 116,504 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $84,690 | 121,511 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $125,916 | 136,424 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $141,265 | 115,794 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $139,644 | 105,794 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $392,964 | 98,241 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $785,754 | 145,242 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $851,425 | 123,039 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,027,708 | 113,685 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,018,491 | 109,398 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $877,536 | 105,600 | Call | Defined | 2021-02-16 | |
| 2020-12-31 | $2,685,792 | 323,200 | Put | Defined | 2021-02-16 | |
| 2020-12-31 | $918,750 | 110,560 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,502,880 | 323,200 | Put | Defined | 2020-11-16 | |
| 2020-09-30 | $449,689 | 96,708 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 | $491,040 | 105,600 | Call | Defined | 2020-11-16 | |
| 2020-06-30 | $1,311,552 | 105,600 | Call | Defined | 2020-08-14 | |
| 2020-06-30 | $1,324,106 | 106,611 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $4,014,144 | 323,200 | Put | Defined | 2020-08-14 | |
| 2020-03-31 | $1,126,952 | 1,243,880 | Shares | Defined | 2020-06-16 | |
| 2020-03-31 | $292,819 | 323,200 | Put | Defined | 2020-06-16 | |
| 2020-03-31 | $362,399 | 400,000 | Call | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||